Qiagen stock heads into the open after a 0.28 percent gain

At the close on September 9, 2026, Qiagen stock ended the New York Stock Exchange session at 42.50 dollars with a 0.28 percent gain, while the DAX benchmark fell 1.66 percent. Qiagen stock also showed a modest 1.04 percent rise on Xetra that day.

At the close on September 9, 2026, Qiagen stock finished the New York Stock Exchange session at 42.50 dollars, marking a daily gain of 0.28 percent over the prior close. In contrast, the DAX benchmark index declined 1.66 percent on the same date, underscoring the stock's relative resilience against broader weakness in German blue chips.

September 9, 2026 in numbers

Qiagen N.V. (ISIN NL0012169213, NYSE: QGEN) saw its American depositary shares close at 42.50 dollars on the New York Stock Exchange on September 9, 2026, as reported by MarketScreener data cited in a MarketWatch-style wrap that tied this close and the 0.28 percent advance directly to that trading day. Per German market data compiled by boerse.de for the same calendar date, Qiagen's Xetra listing recorded a close at 36.20 euros after trading between 36.19 euros and 36.20 euros, with reported volume of 1,810 shares on September 9, 2026, indicating a relatively tight intraday range and modest turnover in Frankfurt. XTB's DAX trading commentary for that date highlighted Qiagen among the top gainers on Xetra with a 1.04 percent rise, while the index itself posted a notable Xetra loss, emphasizing that Qiagen outperformed the broader German market despite the overall downbeat tone.

Recent coverage by Simply Wall St has framed Qiagen's valuation context by noting that one widely followed narrative places fair value near 45.28 dollars per share, only slightly above the latest New York close at 42.50 dollars, and has linked this view to the company's recent leadership and product news. As Analytical Science reported on September 10, 2026, Qiagen appointed Jonathan M. Pratt as the company's chief executive officer effective September 1, 2026, succeeding Thierry Bernard, a change that continues to shape investor perception of the stock together with ongoing discussion of its diagnostic platforms.

Outlook today, September 11, 2026

Looking ahead to today, September 11, 2026, earnings calendar information summarized from CNN markets data and relayed in a recent markets piece indicates that Qiagen's next scheduled quarterly earnings release is set for November 10, 2026, so no results are due today and the next major fundamental update lies several weeks away. Broader equity-market commentary for September 10, 2026 from Yahoo Finance shows that key United States benchmarks such as the Dow Jones Industrial Average fell around 0.8 percent in the latest completed session, a backdrop that may remain relevant for Qiagen stock as investors assess global risk appetite and sector sentiment into today's trading. With the leadership transition to Jonathan M. Pratt now effective and valuation debates ongoing, Qiagen enters today's session without a specific company event on the calendar but against a mixed market environment that could influence trading in its shares.